From molecular mechanism to therapy for barth syndrome
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110445
- Recipient
-
The Children's Hospital Corporation UEI Z1L9F1MM1RY3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $2,788,724
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Boston, MA 02115, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded Boston Children's Hospital a $2.788 million Project Grant from the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2021 through June 30, 2025.
The grant funds research to develop therapies for Barth Syndrome from the molecular mechanism level. Barth Syndrome is a rare genetic condition that causes cardiac abnormalities and muscle weakness. The Military Medical Research and Development program supports biomedical research to transform military and public health, as well as investigate medical solutions for battlefield care. This award will further the program's goals by advancing the understanding and treatment of Barth Syndrome, a condition that impacts both military and civilian populations.
Quick answers
Who received award W81XWH2110445?
W81XWH2110445 was awarded to The Children's Hospital Corporation by Medical Command (Department of the Army) on July 1, 2021.
How much is award W81XWH2110445 worth?
$2,788,724 has been obligated on W81XWH2110445.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award